Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 17;103(20):e38123.
doi: 10.1097/MD.0000000000038123.

Clinical research progress on intrathecal glucocorticoids in the treatment of infections: A review

Zixv Lv  1 , Yingying Liu  2
Affiliations
Review

Clinical research progress on intrathecal glucocorticoids in the treatment of infections: A review

Zixv Lv et al. Medicine (Baltimore). .

Abstract

In some infectious diseases, pathogenic microorganisms can directly or indirectly cause significant inflammatory reactions in the central nervous system, leading to severe neurological dysfunction, such as suppurative meningitis, tuberculous meningitis, and febrile infections. related epilepsy syndrome, etc. In these diseases, adjuvant administration of glucocorticoids is necessary to inhibit the release of proinflammatory cytokines, and intrathecal administration can deliver the drug more directly to the target. In this article, the authors studied intrathecal glucocorticoids for the treatment of infectious inflammatory reactions in terms of pharmacological effects and mechanisms, pharmacokinetics, clinical application, and safety. The authors concluded that the article could help provide new treatment strategies for infectious diseases.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

References

    1. Gundamraj S, Hasbun R. The use of adjunctive steroids in central nervous infections. Front Cell Infect Microbiol. 2020;10:592017. - PMC - PubMed
    1. Witt KA, Sandoval KE. Steroids and the blood–brain barrier: therapeutic implications. Adv Pharmacol. 2014;71:361–90. - PubMed
    1. Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018;29:42–54. - PubMed
    1. Borgia R, Caccianiga G. T lymphocyte interaction in the central nervous system. Eur J Neurodegener Dis. 2023;12:94–8.
    1. Daliu P, Scarano A. IL-4, IL-1 receptor antagonist, Il-37, and Il-38 Inhibit Il-1 and Tnf Generated By Microglia. Eur J Neurodegener Dis. 2023;12:99–102.